Huang C, Wang Y, Li X, Ren L, Zhao J, Hu y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.
 World Health Organization. https://www.who.int/emergencies/diseases/novel coronavirus–2019Accessed Feb 7, 2020.
 Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nature reviews. Microbiology.2019;17:181–92.
 Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–733.
 Jiang, Y, Xu, J, Zhou, C, Wu, Z, Zhong, S, Liu, J, et al. Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome. Am J RespirCrit Care Med. 2005; 171, 850–857.
 Niu, P, Zhao, G, Deng, Y, Sun, S, Wang, W, Zhou, Y, et al. A novel human mAb (MERS-GD27) provides prophylactic and postexposure efficacy in MERS-CoV susceptible mice. Sci China Life Sci. 2018; 61, 1280–1282
 Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.NEngl J Med. 2020; doi: 10.1056/NEJMoa2001316.
 NHC. http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df3517 da8aefc2.shtml. (accessed Feb 19, 2020)
 Pan Y, Guan H, Zhou S, Wang Y, Li Q, Zhu T, et al. Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China. EurRadiol. 2020. doi: 10.1007/s00330–020–06731-x.
 Xie X, Zhong Z, Zhao W, Zheng C, Wang F, Liu J. Chest CT for Typical 2019-nCoV Pneumonia: Relationship to Negative RT-PCR Testing. Radiology. 2020. doi: 10.1148/radiol.2020200343.
 WHO. Novel coronavirus-China. Jan 12, 2020. http://www.who.int/csr/don/ 12-january–2020-novel-coronavirus-china/en/ (accessedJan 19, 2020).
 Bi, Y, Tan, S, Yang, Y, Wong, G, Zhao, M, Zhang, Q, et al. Clinical and immunological characteristics of human infections with H5N6 avian influenza virus. Clin Infect Dis. 2019; 68, 1100–1109.
 Sanz F, Gimeno C, Lloret T, et al. Relationship between thepresence of hypoxemia and the inflammatory response measuredby C-reactive protein in bacteremic pneumococcal pneumonia.EurRespir J. 2011; 38: 2492.
 Hui, D. S. C.; Zumla, A. Severe acute respiratory syndrome: Historical, epidemiologic, and clinical features. Infect. Dis. Clin. North Am. 2019, 33, 869–889.
 Killerby, ME.; Biggs, HM.; Midgley, CM.; Gerber, SI.; Watson, JT. Middle East respiratory syndrome coronavirus transmission. Emerg. Infect. Dis. 2020, 26, 191–198.
 Nikkei Asian Review.https://asia.nikkei.com/Spotlight/Coronavirusoutbreak/ CoronaviruslatestUScitizendiesinWuhanafterinfection.Accessed February 8, 2020.
 CNN Business. https://edition.cnn.com/2020/01/31/economy/chinaeconomy- coronavirus/index.html.Accessed February 9, 2020.
 Guan WJ, Ni ZY, Hu Y, Liang WH, OuCQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China.NEngl J Med. 2020; doi: 10.1056/NEJMoa2002032.
 Leung WK, To KF, Chan PK, Chan HL, Wu AK, Lee N, et al. Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection. Gastroenterology 2003; 125: 1011–7.
 Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, Al-Barrak A, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis 2013; 13: 752–61.
 MahallawiWH, Khabour OF, Zhang Q, Makhdoum HM, Suliman BA. MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile. Cytokine 2018; 104: 8–13.
 Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.Lancet. 2020;395:507–513.
 Wong CK, Lam CWK, Wu AKL, Ip WK, Lee NL, Chan IH, et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. ClinExpImmunol 2004; 136: 95–103.
 Liu WJ, Zhao M, Liu K, Xu K4, Wong G5, Tan W, et al. T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV. Antiviral Res 2017; 137: 82–92.
 Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020.doi: 10.1007/s11427–020–1643–8.
 Arabi YM, Alothman A, Balkhy HH, Al-Dawood A, AlJohani S, Al Harbi S, et al. Treatment of Middle East respiratory syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial. Trials 2018; 19: 81.
 Yang W, Cao Q, Qin L, Wang X, Cheng Z, Pan A, et al. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID–19):A multi-center study in Wenzhou city, Zhejiang, China. J Infect. 2020; pii: S0163–4453(20)30099–2. doi: 10.1016/j.jinf.2020.02.016.